Johnson and Johnson raises figures, estimates $2.5 billion in COVID-19 vaccine deals Kumar Jeetendra | July 21, 2021 Johnson & Johnson on Wednesday raised its overall revenue estimate for the year and forecast $2.5 billion in sales of its COVID-19 vaccine, which has fallen way behind rival shots from Pfizer and Moderna as the company deals with vaccine production issues and safety concerns. Although Johnson & Johnson’s shot was approved in the United …
China says ”shocked” by WHO plan for COVID source: Study Kumar Jeetendra | July 22, 2021 A senior Chinese health official said Thursday he was shocked by the World Health Organisation’s plan for the second phase of a COVID-19 origins study. National Health Commission Vice Minister Zeng Yixin dismissed the lab leak theory as a rumor running counter to common sense. The head of the WHO acknowledged last week that it …
New COVID variant ‘likely’ this year: Top French master Kumar Jeetendra | July 23, 2021 The French government’s top advisor on COVID-19 warned Friday that a new variant of the disease would “probably” emerge in the winter months this year. The country is currently battling an unprecedented spike in new cases caused by the more infectious Delta variant, which was first recorded in India. “We will probably have another variant …
AstraZeneca to look for US approval of Coronavirus immunization in second half Kumar Jeetendra | July 29, 2021 AstraZeneca said on Thursday that it intends to seek US authorization for its COVID-19 vaccine in the second half of this year, offering a new timetable for the much-delayed application. The Anglo-Swedish drugmaker announced the schedule as it released second-quarter financial results, which showed that the company and its sub-licensees delivered more than 700 million …
Hard-won increases in risk as Delta variant spreads: WHO Kumar Jeetendra | August 1, 2021 The world is at risk of losing hard-won gains in fighting COVID-19 as the highly transmissible Delta variant spreads, but WHO-approved vaccines remain effective, the World Health Organization said on Friday. The U.S. Centers for Disease Control and Prevention (CDC) has described the Delta variant of the coronavirus as being as transmissible as chickenpox and …
Consolidating AstraZeneca and mRNA COVID-19 vaccine is effective – Danish study Kumar Jeetendra | August 2, 2021 Combining AstraZeneca’s COVID-19 vaccine with a second dose from either Pfizer-BioNTech or Moderna’s jab provides “good protection”, Denmark’s State Serum Institute said on Monday. A growing number of countries are looking at switching to different COVID-19 vaccines for second doses, a measure particularly necessary in Denmark after health authorities discontinued inoculations with AstraZeneca’s vaccine in …
WHO calls for ban on COVID-19 vaccine booster dose Kumar Jeetendra | August 4, 2021 The World Health Organization is calling for a moratorium on COVID-19 vaccine boosters until at least the end of September, its head Tedros Adhanom Ghebreyesus said on Wednesday. The move was to enable that at least 10% of the population of every country was vaccinated, Tedros said. “I understand the concern of all governments to …
Provided more than 1 billion COVID-19 vaccine dose up until now: BioNTech Kumar Jeetendra | August 9, 2021 BioNTech and partner Pfizer have supplied more than one billion doses of their COVID-19 vaccine as per July 21, a bigger number than delivered by competitor AstraZeneca, the German biotech group said on Monday. The supply tally, up from more than 700 million doses announced by the biotech firm in June, compares with AstraZeneca saying …
Wockhardt inks agreement to deliver, supply Sputnik vaccine to Dubai-based firm Kumar Jeetendra | August 13, 2021 Drug maker Wockhardt on Friday said it has inked a pact with Dubai-based Enso Healthcare and a subsidiary of Russian Direct Investment Fund (RDIF) for production and supply of COVID-19 vaccine Sputnik. The Mumbai-based firm has entered into an agreement with Enso and Human Vaccine LLC , a wholly owned unit of the management company of RDIF …
India considers continuing vaccine export soon,focus around Africa, says source Kumar Jeetendra | September 15, 2021 India is considering resuming exports of COVID-19 vaccines soon, mainly to Africa, as it has partly immunised a majority of its adults and supplies have surged, a source with knowledge of the matter told Reuters. India, the world’s biggest maker of vaccines overall, stopped vaccine exports in April to focus on inoculating its own population …
Pfizer starts investigation of oral drug for counteraction of COVID-19 Kumar Jeetendra | September 27, 2021 Pfizer Inc said on Monday it has started a mid-to-late-stage study testing its investigational oral antiviral drug for the prevention of COVID-19 infection among those who have been exposed to the virus. The company and its rivals, including U.S.-based Merck & Co Inc and Swiss pharmaceutical Roche Holding AG, have been racing to develop the …
New drug Molnupiravir can be the solution for our fight against COVID-19 Kumar Jeetendra | December 28, 2021 Mumbai, 28th December 2021: As countries prepare themselves to fight a possible ‘next wave’. The new variant – Omicron has been making headline and a surge in covid 19 cases are evident. According to a study based on population-level evidence, the recently identified Omicron variant of SARS-CoV-2 is associated with a substantial ability to evade …
